BACKGROUND DATA AND OBJECTIVE: Patients who have received high doses ofchemotherapy, either alone or in combination with total body irradiation often cite oral mucositis (OM) as the most debilitating side effect. The aim of this study was to investigate the clinical effects of low-level laser therapy (LLLT) on the prevention of conditioning-induced OM in hematopoietic stem cell transplantation (HSCT). METHODS: We randomized 42 patients who underwentautologous or allogeneic HSCT. A low-level InGaAlP diode laser was used, emitting light at 660 nm, 40 mW, and 4 J/cm(2). An evaluation of OM was carried out using the World Health Organization scale. RESULTS AND CONCLUSION: In the LLLT group, 57.1% of patients had an OM grade 0, 9.6% had grade 1, and 33.3% had grade 2, whereas in the control group, only 4.8% of patients were free of OM (grade 0). Our results indicate that the preventive use of LLLT in patients who have undergone HSCT is a powerful instrument in reducing OM incidence.
RCT Entities:
BACKGROUND DATA AND OBJECTIVE:Patients who have received high doses of chemotherapy, either alone or in combination with total body irradiation often cite oral mucositis (OM) as the most debilitating side effect. The aim of this study was to investigate the clinical effects of low-level laser therapy (LLLT) on the prevention of conditioning-induced OM in hematopoietic stem cell transplantation (HSCT). METHODS: We randomized 42 patients who underwent autologous or allogeneic HSCT. A low-level InGaAlP diode laser was used, emitting light at 660 nm, 40 mW, and 4 J/cm(2). An evaluation of OM was carried out using the World Health Organization scale. RESULTS AND CONCLUSION: In the LLLT group, 57.1% of patients had an OM grade 0, 9.6% had grade 1, and 33.3% had grade 2, whereas in the control group, only 4.8% of patients were free of OM (grade 0). Our results indicate that the preventive use of LLLT in patients who have undergone HSCT is a powerful instrument in reducing OM incidence.
Authors: Betânia Ferreira; Fabiana Moura da Motta Silveira; Flávia Augusta de Orange Journal: Support Care Cancer Date: 2015-08-07 Impact factor: 3.603
Authors: Letícia Mello Bezinelli; Luciana Corrêa; Cristina Vogel; Jose Mauro Kutner; Andreza Feitosa Ribeiro; Nelson Hamerschlak; Carlos de Paula Eduardo; Cesar Augusto Migliorati; Fernanda de Paula Eduardo Journal: Support Care Cancer Date: 2021-05-22 Impact factor: 3.603
Authors: Heliton S Antunes; Gabriel Wajnberg; Marcos B Pinho; Natasha Andressa Nogueira Jorge; Joyce Luana Melo de Moraes; Claudio Gustavo Stefanoff; Daniel Herchenhorn; Carlos M M Araújo; Celia Maria Pais Viégas; Mariana P Rampini; Fernando L Dias; Patricia Savio de Araujo-Souza; Fabio Passetti; Carlos G Ferreira Journal: Lasers Med Sci Date: 2017-08-24 Impact factor: 3.161
Authors: Ysabella Z A Van Sebille; Romany Stansborough; Hannah R Wardill; Emma Bateman; Rachel J Gibson; Dorothy M Keefe Journal: Curr Oncol Rep Date: 2015-11 Impact factor: 5.075